http://www.ft.com/lex/drugshttp://www.ft.com/rss/lex/drugsFT.com - Lex, Drugs & healthcareen© Copyright The Financial Times Ltd 2009. "FT" and "Financial Times" are trademarks of the Financial Times. See http://www.ft.com/servicestools/help/terms#legal1 for the terms and conditions of reuse.client.support@ft.com (Client Support)Mon, 2 Nov 2009 23:02:39 +0000Mon, 23 Nov 2009 05:50:29 +0000Newspapers15http://news.ft.com/cms/d1f3ce1a-6bbe-11da-bb53-0000779e2340.gifhttp://www.ft.com/lex/drugs(PICS-1.1 "http://www.classify.org/safesurf/" L gen true for "http://www.ft.com/" r (SS~~000 1))http://traxfer.ft.com/cms/s/3/5f8dfe84-c792-11de-8ba8-00144feab49a.html?o=%2Frss%2Flex%2Fdrugshttp://www.ft.com/cms/s/3/5f8dfe84-c792-11de-8ba8-00144feab49a.htmlA commitment to spend hundreds of millions of dollars on developing obesity drugs is the latest move by a Japanese drugmaker to shore up growth by expanding abroadMon, 2 Nov 2009 23:02:39 +0000http://traxfer.ft.com/cms/s/3/b326c098-c536-11de-8193-00144feab49a.html?o=%2Frss%2Flex%2Fdrugshttp://www.ft.com/cms/s/3/b326c098-c536-11de-8193-00144feab49a.htmlFor the managed care companies at the centre of America's health system, the political horse-trading has sent their shares gyratingFri, 30 Oct 2009 19:00:28 +0000http://traxfer.ft.com/cms/s/3/73f5a600-c46e-11de-912e-00144feab49a.html?o=%2Frss%2Flex%2Fdrugshttp://www.ft.com/cms/s/3/73f5a600-c46e-11de-912e-00144feab49a.htmlBosses of most drug companies must wish they had the Danish drugmaker's problems. What is the secret of its success?Thu, 29 Oct 2009 22:22:24 +0000http://traxfer.ft.com/cms/s/3/d5897cf4-b8c8-11de-809b-00144feab49a.html?o=%2Frss%2Flex%2Fdrugshttp://www.ft.com/cms/s/3/d5897cf4-b8c8-11de-809b-00144feab49a.htmlNow that one version of the healthcare reform has passed a key Senate committee, supporters face a determined new opponent – one another.Wed, 14 Oct 2009 22:19:09 +0100http://traxfer.ft.com/cms/s/3/07b5b238-b4dc-11de-8b17-00144feab49a.html?o=%2Frss%2Flex%2Fdrugshttp://www.ft.com/cms/s/3/07b5b238-b4dc-11de-8b17-00144feab49a.htmlIn the US, decay is often more ruinous than death and some insurers are more ill than their customers Fri, 9 Oct 2009 20:51:29 +0100http://traxfer.ft.com/cms/s/3/92603942-b31c-11de-ac13-00144feab49a.html?o=%2Frss%2Flex%2Fdrugshttp://www.ft.com/cms/s/3/92603942-b31c-11de-ac13-00144feab49a.htmlThe French conglomerate's decision to spin off a majority stake in CFAO, its African car and drugs distribution arm, is welcomeWed, 7 Oct 2009 19:15:56 +0100http://traxfer.ft.com/cms/s/3/40f75a32-ac09-11de-950b-00144feabdc0.html?o=%2Frss%2Flex%2Fdrugshttp://www.ft.com/cms/s/3/40f75a32-ac09-11de-950b-00144feabdc0.htmlThe US pharma group's acquisition of the Belgian drugs company is about earnings and better access to overseas markets Mon, 28 Sep 2009 22:39:55 +0100http://traxfer.ft.com/cms/s/3/7feed13a-ac08-11de-950b-00144feabdc0.html?o=%2Frss%2Flex%2Fdrugshttp://www.ft.com/cms/s/3/7feed13a-ac08-11de-950b-00144feabdc0.htmlThe latest deal by China's largest chemicals trader illustrates the growing verve of outbound M&A efforts by China's state-owned enterprisesMon, 28 Sep 2009 22:28:34 +0100http://traxfer.ft.com/cms/s/3/24163718-a9b0-11de-a3ce-00144feabdc0.html?o=%2Frss%2Flex%2Fdrugshttp://www.ft.com/cms/s/3/24163718-a9b0-11de-a3ce-00144feabdc0.htmlThe experimental vaccine that appears to reduce the rate of infection is a promising first jab in a big fightFri, 25 Sep 2009 22:59:34 +0100http://traxfer.ft.com/cms/s/3/0cd0ff68-9865-11de-807a-00144feabdc0.html?o=%2Frss%2Flex%2Fdrugshttp://www.ft.com/cms/s/3/0cd0ff68-9865-11de-807a-00144feabdc0.htmlLong content to slug it out in their fragmented, $70bn-a-year domestic market, Japanese drugmakers have had something of a coming-out partyThu, 3 Sep 2009 19:59:23 +0100http://traxfer.ft.com/cms/s/3/38312602-9247-11de-b63b-00144feabdc0.html?o=%2Frss%2Flex%2Fdrugshttp://www.ft.com/cms/s/3/38312602-9247-11de-b63b-00144feabdc0.htmlSince medical technology became a separate industry in its own right, investors have been obsessed. But complications have developed Wed, 26 Aug 2009 22:50:25 +0100http://traxfer.ft.com/cms/s/3/88df57ba-90b5-11de-bc99-00144feabdc0.html?o=%2Frss%2Flex%2Fdrugshttp://www.ft.com/cms/s/3/88df57ba-90b5-11de-bc99-00144feabdc0.htmlRather than cost savings, the integration will likely require additional spending to manage the expanded operationsMon, 24 Aug 2009 18:58:01 +0100